Advertisement Roxane launches calcium acetate capsules, 667mg - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roxane launches calcium acetate capsules, 667mg

Roxane Laboratories has received the FDA approval for its abbreviated new drug application for calcium acetate capsules, 667mg.

The product is available in bottles of 200 capsules for immediate shipment to wholesalers and pharmacies nationwide.

Roxane Laboratories’s calcium acetate capsules, 667mg are AB rated to PhosLo capsules.